Hermabivaba
Hermabivaba reported total assets of €1.10m at the end of the 2025 financial year (annual accounts filed with the NBB on 25 Aug 2026).
The score of Hermabivaba shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -1 % Total assets 0 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Hermabivaba's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 25 Aug 2026
- Year ended 31 Dec 2024filed on 01 Jul 2025
- Year ended 31 Dec 2023filed on 30 Jul 2024
- Year ended 31 Dec 2022filed on 06 Jul 2023
- Year ended 31 Dec 2021filed on 28 Jun 2022
Hermabivaba's financial analysis
- Solvency97.7%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Hermabivaba
Hermabivaba's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0687.547.975
- VAT number
- BE0687547975
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Incorporated
- 05 Jan 2018
- Registered office
- 2460 Kasterlee
- Latest accounts
- 2025 · filed on 25 Aug 2026
- Activity
- Activities of holding companies (NACE 64210)
Hermabivaba has been based in Kasterlee since 2018, active in: activities of holding companies. For 2025, it reports a net loss of 2,347 € and equity of €1.08m; its revenue is not published. Its solvency stands at 97.7%, above the median of its sector (55.6%).
Companies similar to Hermabivaba
Companies in the same business, of comparable size and area, outside its group.
- TRO - Invest Rental and operating of own or leased real estate Ghent · balance sheet €1.10m
- Dr. Peter Vansteenkiste - Nucleaire Geneeskunde Medical specialists activities Mechelen · balance sheet €1.10m
- Societe DE Gestion M.O.U.B.E. Rental and operating of own or leased real estate Philippeville · balance sheet €1.10m
- Immo - Select Other activities auxiliary to financial services, except insurance and pension funding Zonnebeke · balance sheet €1.10m
- Carrosserie Maes JOS Machining of metals Hechtel-Eksel · balance sheet €1.10m
- N&R Invest Grez-Doiceau · balance sheet €1.10m
- DR.Johan VAN Stee Other education n.e.c. Heers · balance sheet €1.10m
- Imar Oudenburg · balance sheet €1.10m
Frequently asked questions about Hermabivaba
What is the revenue of Hermabivaba?
Hermabivaba files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Hermabivaba?
In Belgium, the VAT number is the company number prefixed with BE: BE0687547975 for Hermabivaba, if the company is VAT-registered. Its company number (CBE) is 0687.547.975.
Where is the registered office of Hermabivaba?
According to the CBE register, the registered office of Hermabivaba is in 2460 Kasterlee.
What is the equity of Hermabivaba?
At the close of the 2025 financial year, the equity of Hermabivaba amounts to 1,076,157 €, a solvency of 97.7% of total assets.
Who manages Hermabivaba?
The register lists 1 active mandates at Hermabivaba. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Hermabivaba
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →